At present, TNFSF14-based therapy has shown great efficacy in cancer immunotherapy, which can modify tumor microenvironment by normalizing tumor vessels and significantly improve the infiltration of effector infiltrating lymphocytes, thus reducing tumor burden and forming lasting anti-tumor memory (Skeate et al., 2020). The gene discussed is TNFSF14; the disease is neoplasm.